Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Whooping Cough Vaccines
Study data from I. Rodríguez-Cobo and colleagues update understanding of whooping cough vaccines
February 4th, 2009
New research, 'Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: a systematic review,' is the subject of a report. "Pertussis continues to be an important cause of morbidity and mortality in children too young to be fully protected despite high vaccination coverage. This has been attributed to waning immunity in older people, leading to the development of strategies to increase levels of immunity," investigators in Spain report. "A systematic review was conducted to assess the clinical and cost effectiveness of four...
Source: Vaccine Weekly (2009-02-04)
|
